Juli Miller | IR |
James Noble | CEO |
Helen Tayton-Martin | Chief Business Officer |
Adrian Rawcliffe | CFO |
Rafael Amado | President, Research and Development |
Jonathan Chang | SVB Leerink |
Peter Lawson | Sun Trust Robinson |
Michael Schmidt | Guggenheim Securities |
Marc Frahm | Cowen & Company |
Reni Benjamin | Raymond James |
Soumit Roy | Jones Trading |
Good day, ladies and gentlemen, and welcome to the Adaptimmune Therapeutics Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct question-and-answer session and instructions will be given at that time. [Operator Instructions]. I would now like to introduce your host for today’s conference, Ms.